New Zealand Daily Vaping at 11%, User Numbers Climb to 480,000

Nov.21.2024
New Zealand Daily Vaping at 11%, User Numbers Climb to 480,000
New Zealand's daily vaping rate has surged to 11.1% in 2023/24, with users increasing to 480,000, while daily smoking rates continue to drop.

On November 19, New Zealand's Ministry of Health released the results of the 2023-2024 Health Survey.

 

 

Key Findings for the Total Population (15+)

 

 

Decline in Daily Smoking:


Daily smoking rates have steadily decreased since 2011/12, with an accelerated decline observed from 2019/20 onwards.

 

  • In 2023/24, the daily smoking rate was 6.9%, nearly unchanged from 6.8% in 2022/23, but significantly down from 16.4% in 2011/12.
  • The number of daily smokers dropped from 573,000 in 2011/12 to 300,000 in 2023/24.

 

Rise in Daily Vaping:


Daily vaping prevalence has surged since it was first measured in 2015/16, when it was just 0.9%. After a steady rise in the early years, growth accelerated sharply from 2020/21.

 

  • In 2023/24, the daily vaping rate reached 11.1%, up from 9.7% the previous year.
  • The number of daily vapers increased from 33,000 in 2015/16 to 480,000 in 2023/24.

 

 

Age-Group Insights 

 

 

  • Among 15–17 and 18–24-year-olds, vaping has grown faster than the decline in smoking.
  • For adults aged 25–64, the rise in vape use aligns closely with the decline in smoking.
  • Among 15–44-year-olds, daily vapers now outnumber daily smokers, but this trend is less pronounced for those aged 45–64.
  • For individuals aged 65 and older, smoking rates remain relatively high, with slower adoption of vaping.

 

The Associate Minister of Health, Casey Costello, said: "Most of the survey data shows a continuation of the great progress that's been made in the last few years - especially with falling numbers of Māori smokers and very low rates of youth smoking".
 

"Early next year I will also take proposals to cabinet for an improved regulatory regime around all nicotine and tobacco products with a view to having a system that is aimed at reducing harm, that is coherent across products, and enforceable".

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.